QLT News
Most Popular QLT Story
QLT stock rockets as acne drug is cleared for takeoff
Shares of QLT rocketed up 55 percent in a tense market yesterday after the biotech finished a lengthy task in persuading the FDA that a blood test should not be required before doctors prescribe its... Read more...
Latest Headlines
- October 2, 2009
- March 18, 2008
- November 28, 2007
- October 9, 2007
- July 16, 2007
- May 18, 2006
- February 28, 2006
- February 13, 2006
- January 3, 2006
- December 8, 2005
- September 20, 2005
- July 19, 2005
- June 7, 2005
Paid Research Reports
- The Specialty Pharma Market Outlook: Key players, new company growth models and emerging opportunities
- Investigating Clinical Trial Costs: Comparative analysis of trial cost components in key geographies
- Clinical Trial Recruitment Strategies: Optimizing patient recruitment and retention in late stage clinical trials
- Pipeline Insight: Therapeutic Cancer Vaccines - Prospect of first approval set to reinvigorate interest from major companies
- Stakeholder Opinions: Vaccines in Emerging Markets (Asia) - Opportunities in China, India, South Korea and Taiwan
- Big Pharma Performance Before, During and Beyond the Global Recession
